{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:00:47Z","timestamp":1780416047914,"version":"3.54.1"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41401-020-00557-5","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T08:03:26Z","timestamp":1605773006000},"page":"1390-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target"],"prefix":"10.1038","volume":"42","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-guo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"557_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","volume":"75","author":"JI Mechanick","year":"2020","unstructured":"Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:525\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"557_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostrom","year":"2012","unstructured":"Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463\u20138.","journal-title":"Nature."},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0378-1119(02)00828-4","volume":"297","author":"A Teufel","year":"2002","unstructured":"Teufel A, Malik N, Mukhopadhyay M, Westphal H. Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. Gene. 2002;297:79\u201383.","journal-title":"Gene."},{"key":"557_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/dvdy.10099","volume":"224","author":"A Ferrer-Martinez","year":"2002","unstructured":"Ferrer-Martinez A, Ruiz-Lozano P, Chien KR. Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development. Dev Dyn. 2002;224:154\u201367.","journal-title":"Dev Dyn"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"e60563","DOI":"10.1371\/journal.pone.0060563","volume":"8","author":"A Roca-Rivada","year":"2013","unstructured":"Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen CA, et al. FNDC5\/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563.","journal-title":"PLoS One"},{"key":"557_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020;27:540\u201355.","journal-title":"Cell Death Differ"},{"key":"557_CR7","doi-asserted-by":"crossref","unstructured":"Zhang X, Hu C, Yuan YP, Ma ZG, Tang QZ. A brief overview about the physiology of fibronectin type III domain-containing 5. Cell Signal. 2020;76:109805.","DOI":"10.1016\/j.cellsig.2020.109805"},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41401-019-0230-z","volume":"40","author":"Q Liao","year":"2019","unstructured":"Liao Q, Qu S, Tang LX, Li LP, He DF, Zeng CY, et al. Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis. Acta Pharmacol Sin. 2019;40:1314\u201321.","journal-title":"Acta Pharmacol Sin"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/HJH.0000000000001654","volume":"36","author":"L Ling","year":"2018","unstructured":"Ling L, Chen D, Tong Y, Zang YH, Ren XS, Zhou H, et al. Fibronectin type III domain containing 5 attenuates NLRP3 inflammasome activation and phenotypic transformation of adventitial fibroblasts in spontaneously hypertensive rats. J Hypertens. 2018;36:1104\u201314.","journal-title":"J Hypertens"},{"key":"557_CR10","doi-asserted-by":"publisher","first-page":"eaao6298","DOI":"10.1126\/scitranslmed.aao6298","volume":"9","author":"K Chen","year":"2017","unstructured":"Chen K, Xu Z, Liu Y, Wang Z, Li Y, Xu X, et al. Irisin protects mitochondria function during pulmonary ischemia\/reperfusion injury. Sci Transl Med. 2017;9:eaao6298.","journal-title":"Sci Transl Med"},{"key":"557_CR11","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.2337\/db16-0356","volume":"65","author":"TY Liu","year":"2016","unstructured":"Liu TY, Xiong XQ, Ren XS, Zhao MX, Shi CX, Wang JJ, et al. FNDC5 alleviates hepatosteatosis by restoring AMPK\/mTOR-mediated autophagy, fatty acid oxidation, and lipogenesis in mice. Diabetes. 2016;65:3262\u201375.","journal-title":"Diabetes."},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.cell.2018.10.025","volume":"175","author":"H Kim","year":"2018","unstructured":"Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, et al. Irisin mediates effects on bone and fat via \u03b1V integrin receptors. Cell. 2018;175:1756\u201368.","journal-title":"Cell."},{"key":"557_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01646-6","volume":"8","author":"H Peng","year":"2017","unstructured":"Peng H, Wang Q, Lou T, Qin J, Jung S, Shetty V, et al. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun. 2017;8:1493.","journal-title":"Nat Commun"},{"key":"557_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrendo.2016.221","volume":"13","author":"N Perakakis","year":"2017","unstructured":"Perakakis N, Triantafyllou GA, Fernandez-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13:324\u201337.","journal-title":"Nat Rev Endocrinol"},{"key":"557_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.bbadis.2015.06.017","volume":"1852","author":"XQ Xiong","year":"2015","unstructured":"Xiong XQ, Chen D, Sun HJ, Ding L, Wang JJ, Chen Q, et al. FNDC5 overexpression and irisin ameliorate glucose\/lipid metabolic derangements and enhance lipolysis in obesity. Biochim Biophys Acta. 2015;1852:1867\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"557_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","volume":"121","author":"RL Li","year":"2018","unstructured":"Li RL, Wu SS, Wu Y, Wang XX, Chen HY, Xin JJ, et al. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway. J Mol Cell Cardiol. 2018;121:242\u201355.","journal-title":"J Mol Cell Cardiol"},{"key":"557_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","volume":"124","author":"A Benetos","year":"2019","unstructured":"Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124:1045\u201360.","journal-title":"Circ Res"},{"key":"557_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/10641963.2016.1273945","volume":"39","author":"LJ Zhang","year":"2017","unstructured":"Zhang LJ, Xie Q, Tang CS, Zhang AH. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia. Clin Exp Hypertens. 2017;39:460\u20137.","journal-title":"Clin Exp Hypertens"},{"key":"557_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.numecd.2018.04.009","volume":"28","author":"F De Meneck","year":"2018","unstructured":"De Meneck F, Victorino DSL, Oliveira V, Do FM. High irisin levels in overweight\/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells. Nutr Metab Cardiovasc Dis. 2018;28:756\u201364.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.7754\/Clin.Lab.2015.150420","volume":"61","author":"HT Celik","year":"2015","unstructured":"Celik HT, Akkaya N, Erdamar H, Gok S, Kazanci F, Demircelik B, et al. The effects of valsartan and amlodipine on the levels of irisin, adropin, and perilipin. Clin Lab. 2015;61:1889\u201395.","journal-title":"Clin Lab"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.metabol.2015.05.005","volume":"64","author":"LA Brondani","year":"2015","unstructured":"Brondani LA, Boelter G, Assmann TS, Leitao CB, Canani LH, Crispim D. Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men. Metabolism. 2015;64:952\u20137.","journal-title":"Metabolism."},{"key":"557_CR22","doi-asserted-by":"publisher","first-page":"e19365","DOI":"10.1097\/MD.0000000000019365","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang H, Wang X, Cao Y, Han W, Guo Y, Yang G, et al. Association of polymorphisms of preptin, irisin and adropin genes with susceptibility to coronary artery disease and hypertension. Medicine. 2020;99:e19365.","journal-title":"Medicine"},{"key":"557_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.119.13777","volume":"75","author":"CY Carmichael","year":"2020","unstructured":"Carmichael CY, Kuwabara JT, Pascale CL, Moreira JD, Mahne SE, Kapusta DR, et al. Hypothalamic paraventricular nucleus G\u03b1i2 (guanine nucleotide-binding protein alpha inhibiting activity polypeptide 2) protein-mediated neural control of the kidney and the salt sensitivity of blood pressure. Hypertension. 2020;75:1002\u201311.","journal-title":"Hypertension."},{"key":"557_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.119.13133","volume":"74","author":"S Mukerjee","year":"2019","unstructured":"Mukerjee S, Gao H, Xu J, Sato R, Zsombok A, Lazartigues E. ACE2 and ADAM17 interaction regulates the activity of presympathetic neurons. Hypertension. 2019;74:1181\u201391.","journal-title":"Hypertension."},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"114953","DOI":"10.1016\/j.taap.2020.114953","volume":"394","author":"CJ Huo","year":"2020","unstructured":"Huo CJ, Yu XJ, Sun YJ, Li HB, Su Q, Bai J, et al. Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats. Toxicol Appl Pharmacol. 2020;394:114953.","journal-title":"Toxicol Appl Pharmacol"},{"key":"557_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/cen.12658","volume":"83","author":"N Hou","year":"2015","unstructured":"Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol. 2015;83:339\u201343.","journal-title":"Clin Endocrinol"},{"key":"557_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2014.04.036","volume":"235","author":"L Xiang","year":"2014","unstructured":"Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis. 2014;235:328\u201333.","journal-title":"Atherosclerosis."},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1139\/apnm-2019-0602","volume":"45","author":"K Inoue","year":"2020","unstructured":"Inoue K, Fujie S, Hasegawa N, Horii N, Uchida M, Iemitsu K, et al. Aerobic exercise training-induced irisin secretion is associated with the reduction of arterial stiffness via nitric oxide production in adults with obesity. Appl Physiol Nutr Metab. 2020;45:715\u201322.","journal-title":"Appl Physiol Nutr Metab"},{"key":"557_CR29","doi-asserted-by":"publisher","first-page":"e003433","DOI":"10.1161\/JAHA.116.003433","volume":"5","author":"J Fu","year":"2016","unstructured":"Fu J, Han Y, Wang J, Liu Y, Zheng S, Zhou L, et al. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat. J Am Heart Assoc. 2016;5:e003433.","journal-title":"J Am Heart Assoc"},{"key":"557_CR30","doi-asserted-by":"publisher","first-page":"H1501","DOI":"10.1152\/ajpheart.00443.2015","volume":"309","author":"F Han","year":"2015","unstructured":"Han F, Zhang S, Hou N, Wang D, Sun X. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol. 2015;309:H1501\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"557_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2017.10.160","volume":"495","author":"L Ye","year":"2018","unstructured":"Ye L, Xu M, Hu M, Zhang H, Tan X, Li Q, et al. TRPV4 is involved in irisin-induced endothelium-dependent vasodilation. Biochem Biophys Res Commun. 2018;495:41\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2015.07.015","volume":"87","author":"D Zhu","year":"2015","unstructured":"Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F, et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative\/nitrative stresses. J Mol Cell Cardiol. 2015;87:138\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"557_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.bbrc.2015.11.040","volume":"468","author":"M Jiang","year":"2015","unstructured":"Jiang M, Wan F, Wang F, Wu Q. Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms. Biochem Biophys Res Commun. 2015;468:832\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"557_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2016.07.052","volume":"479","author":"H Song","year":"2016","unstructured":"Song H, Xu J, Lv N, Zhang Y, Wu F, Li H, et al. Irisin reverses platelet derived growth factor-BB-induced vascular smooth muscle cells phenotype modulation through STAT3 signaling pathway. Biochem Biophys Res Commun. 2016;479:139\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"557_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.clinbiochem.2014.08.017","volume":"47","author":"R Alis","year":"2014","unstructured":"Alis R, Sanchis-Gomar F, Pareja-Galeano H, Hernandez-Mijares A, Romagnoli M, Victor VM, et al. Association between irisin and homocysteine in euglycemic and diabetic subjects. Clin Biochem. 2014;47:333\u20135.","journal-title":"Clin Biochem"},{"key":"557_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1152\/physrev.00004.2012","volume":"93","author":"PN Hopkins","year":"2013","unstructured":"Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317\u2013542.","journal-title":"Physiol Rev"},{"key":"557_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00592-014-0576-0","volume":"51","author":"G Sesti","year":"2014","unstructured":"Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014;51:705\u201313.","journal-title":"Acta Diabetol"},{"key":"557_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2015.08.002","volume":"242","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Lee SA, Nam BY, Park S, Lee SH, Ryu HJ, et al. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis. 2015;242:476\u201382.","journal-title":"Atherosclerosis."},{"key":"557_CR39","doi-asserted-by":"publisher","first-page":"e206761","DOI":"10.1371\/journal.pone.0206761","volume":"13","author":"MK Saadeldin","year":"2018","unstructured":"Saadeldin MK, Elshaer SS, Emara IA, Maged M, Abdel-Aziz AK. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: a case control study. PLoS One. 2018;13:e206761.","journal-title":"PLoS One"},{"key":"557_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/cen.13800","volume":"89","author":"O Moreno-Perez","year":"2018","unstructured":"Moreno-Perez O, Reyes-Garcia R, Munoz-Torres M, Merino E, Boix V, Reus S, et al. High irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis. Clin Endocrinol. 2018;89:414\u201323.","journal-title":"Clin Endocrinol"},{"key":"557_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/jim-2015-000044","volume":"64","author":"A Icli","year":"2016","unstructured":"Icli A, Cure E, Cumhur CM, Uslu AU, Balta S, Arslan S, et al. Novel myokine: Irisin may be an independent predictor for subclinic atherosclerosis in Behcet\u2019s disease. J Investig Med. 2016;64:875\u201381.","journal-title":"J Investig Med"},{"key":"557_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2018.05.075","volume":"267","author":"T Hisamatsu","year":"2018","unstructured":"Hisamatsu T, Miura K, Arima H, Fujiyoshi A, Kadota A, Kadowaki S, et al. Relationship of serum irisin levels to prevalence and progression of coronary artery calcification: a prospective, population-based study. Int J Cardiol. 2018;267:177\u201382.","journal-title":"Int J Cardiol"},{"key":"557_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ebiom.2016.02.041","volume":"6","author":"H Tang","year":"2016","unstructured":"Tang H, Yu R, Liu S, Huwatibieke B, Li Z, Zhang W. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling. EBioMedicine 2016;6:139\u201348.","journal-title":"EBioMedicine"},{"key":"557_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.mp.4001854","volume":"11","author":"IJ Martins","year":"2006","unstructured":"Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer\u2019s disease and cardiovascular disease. Mol Psychiatry. 2006;11:721\u201336.","journal-title":"Mol Psychiatry"},{"key":"557_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/01.ATV.0000201282.64751.47","volume":"26","author":"J Heeren","year":"2006","unstructured":"Heeren J, Beisiegel U, Grewal T. Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:442\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"557_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-4194-4","volume":"18","author":"N Fuku","year":"2017","unstructured":"Fuku N, Diaz-Pena R, Arai Y, Abe Y, Zempo H, Naito H, et al. Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE. BMC Genom. 2017;18:803.","journal-title":"BMC Genom"},{"key":"557_CR47","doi-asserted-by":"publisher","first-page":"e110273","DOI":"10.1371\/journal.pone.0110273","volume":"9","author":"H Song","year":"2014","unstructured":"Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, et al. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis. PLoS One. 2014;9:e110273.","journal-title":"PLoS One"},{"key":"557_CR48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10753-017-0685-3","volume":"41","author":"X Deng","year":"2018","unstructured":"Deng X, Huang W, Peng J, Zhu TT, Sun XL, Zhou XY, et al. Irisin alleviates advanced glycation end products-induced inflammation and endothelial dysfunction via inhibiting ROS-NLRP3 inflammasome signaling. Inflammation. 2018;41:260\u201375.","journal-title":"Inflammation."},{"key":"557_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/FJC.0000000000000386","volume":"68","author":"G Zhu","year":"2016","unstructured":"Zhu G, Wang J, Song M, Zhou F, Fu D, Ruan G, et al. Irisin increased the number and improved the function of endothelial progenitor cells in diabetes mellitus mice. J Cardiovasc Pharmacol. 2016;68:67\u201373.","journal-title":"J Cardiovasc Pharmacol"},{"key":"557_CR50","first-page":"e158038","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Mu Q, Zhou Z, Song H, Zhang Y, Wu F, et al. Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction. PLoS One. 2016;11:e158038.","journal-title":"PLoS One"},{"key":"557_CR51","doi-asserted-by":"publisher","first-page":"106579","DOI":"10.1016\/j.vph.2019.106579","volume":"121","author":"YH Zang","year":"2019","unstructured":"Zang YH, Chen D, Zhou B, Chen AD, Wang JJ, Gao XY, et al. FNDC5 inhibits foam cell formation and monocyte adhesion in vascular smooth muscle cells via suppressing NF-\u03baB-mediated NLRP3 upregulation. Vasc Pharmacol. 2019;121:106579.","journal-title":"Vasc Pharmacol"},{"key":"557_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-017-0627-2","volume":"16","author":"KS Rana","year":"2017","unstructured":"Rana KS, Pararasa C, Afzal I, Nagel DA, Hill EJ, Bailey CJ, et al. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Cardiovasc Diabetol. 2017;16:147.","journal-title":"Cardiovasc Diabetol"},{"key":"557_CR53","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/01.ATV.10.5.680","volume":"10","author":"ME Rosenfeld","year":"1990","unstructured":"Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680\u20137.","journal-title":"Arteriosclerosis."},{"key":"557_CR54","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","volume":"129","author":"AE Moran","year":"2014","unstructured":"Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1493\u2013501.","journal-title":"Circulation."},{"key":"557_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2017.05.002","volume":"73","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis AD, Koulaxis D, Kefala N, Polyzos SA, Upadhyay J, Pagkalidou E, et al. Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy. Metabolism. 2017;73:1\u20138.","journal-title":"Metabolism."},{"key":"557_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.amjmed.2014.04.025","volume":"127","author":"E Emanuele","year":"2014","unstructured":"Emanuele E, Minoretti P, Pareja-Galeano H, Sanchis-Gomar F, Garatachea N, Lucia A. Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity. Am J Med. 2014;127:888\u201390.","journal-title":"Am J Med"},{"key":"557_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.peptides.2014.02.008","volume":"55","author":"T Kuloglu","year":"2014","unstructured":"Kuloglu T, Aydin S, Eren MN, Yilmaz M, Sahin I, Kalayci M, et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides. 2014;55:85\u201391.","journal-title":"Peptides."},{"key":"557_CR58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.dsx.2018.11.050","volume":"13","author":"ZM Khorasani","year":"2019","unstructured":"Khorasani ZM, Bagheri RK, Yaghoubi MA, Chobkar S, Aghaee MA, Abbaszadegan MR, et al. The association between serum irisin levels and cardiovascular disease in diabetic patients. Diabetes Metab Syndr. 2019;13:786\u201390.","journal-title":"Diabetes Metab Syndr"},{"key":"557_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/1871529X18666180511141151","volume":"18","author":"S Aydin","year":"2018","unstructured":"Aydin S, Catak Z, Eren MN, Topal AE, Aydin S. Irisin in coronary bypass surgery. Cardiovasc Hematol Disord Drug Targets. 2018;18:208\u201314.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"557_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.peptides.2014.04.002","volume":"56","author":"S Aydin","year":"2014","unstructured":"Aydin S, Aydin S, Kobat MA, Kalayci M, Eren MN, Yilmaz M, et al. Decreased saliva\/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides. 2014;56:141\u20135.","journal-title":"Peptides."},{"key":"557_CR61","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.12659\/MSM.897376","volume":"22","author":"W Deng","year":"2016","unstructured":"Deng W. Association of serum irisin concentrations with presence and severity of coronary artery disease. Med Sci Monit. 2016;22:4193\u20137.","journal-title":"Med Sci Monit"},{"key":"557_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1515\/jbcpp-2018-0090","volume":"30","author":"SM Bashar","year":"2018","unstructured":"Bashar SM, Samir ES, Boraie MZ. Correlation between the blood level of irisin and the severity of acute myocardial infarction in exercise-trained rats. J Basic Clin Physiol Pharmacol. 2018;30:59\u201371.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"557_CR63","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1139\/cjpp-2018-0736","volume":"97","author":"EN Abd","year":"2019","unstructured":"Abd EN, Galal HM, El MK, Gadallah AI. Serum irisin level in myocardial infarction patients with or without heart failure. Can J Physiol Pharmacol. 2019;97:932\u20138.","journal-title":"Can J Physiol Pharmacol"},{"key":"557_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ijo.2014.101","volume":"39","author":"KN Aronis","year":"2015","unstructured":"Aronis KN, Moreno M, Polyzos SA, Moreno-Navarrete JM, Ricart W, Delgado E, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes. 2015;39:156\u201361.","journal-title":"Int J Obes"},{"key":"557_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijcard.2017.11.072","volume":"261","author":"IC Hsieh","year":"2018","unstructured":"Hsieh IC, Ho MY, Wen MS, Chen CC, Hsieh MJ, Lin CP, et al. Serum irisin levels are associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Int J Cardiol. 2018;261:12\u20137.","journal-title":"Int J Cardiol"},{"key":"557_CR66","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","volume":"9","author":"C Hu","year":"2019","unstructured":"Hu C, Zhang X, Wei WY, Zhang N, Wu HM, Ma ZG, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPK\u03b1\/UCP2 pathway. Acta Pharm Sin B. 2019;9:690\u2013701.","journal-title":"Acta Pharm Sin B."},{"key":"557_CR67","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/FJC.0000000000000608","volume":"72","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen K, Han Y, Zhu H, Zhou XY, Tan T, et al. Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism. J Cardiovasc Pharmacol. 2018;72:259\u201369.","journal-title":"J Cardiovasc Pharmacol"},{"key":"557_CR68","first-page":"e166182","volume":"11","author":"YT Zhao","year":"2016","unstructured":"Zhao YT, Wang H, Zhang S, Du J, Zhuang S, Zhao TC. Irisin ameliorates hypoxia\/reoxygenation-induced injury through modulation of histone deacetylase 4. PLoS One. 2016;11:e166182.","journal-title":"PLoS One"},{"key":"557_CR69","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.bbrc.2018.07.005","volume":"503","author":"MY Ho","year":"2018","unstructured":"Ho MY, Wen MS, Yeh JK, Hsieh IC, Chen CC, Hsieh MJ, et al. Excessive irisin increases oxidative stress and apoptosis in murine heart. Biochem Biophys Res Commun. 2018;503:2493\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"557_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1718-7","volume":"10","author":"FY Liu","year":"2019","unstructured":"Liu FY, Fan D, Yang Z, Tang N, Guo Z, Ma SQ, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10:480.","journal-title":"Cell Death Dis"},{"key":"557_CR71","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.injury.2018.09.054","volume":"49","author":"G Zhao","year":"2018","unstructured":"Zhao G, Zhang X, Xu P, Mi JY, Rui YJ. The protective effect of Irisin against ischemia-reperfusion injury after perforator flap grafting in rats. Injury. 2018;49:2147\u201353.","journal-title":"Injury."},{"key":"557_CR72","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/CIRCRESAHA.116.309782","volume":"120","author":"S Sharma","year":"2017","unstructured":"Sharma S, Mishra R, Bigham GE, Wehman B, Khan MM, Xu H, et al. A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells. Circ Res. 2017;120:816\u201334.","journal-title":"Circ Res"},{"key":"557_CR73","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/jcp.27037","volume":"234","author":"YT Zhao","year":"2019","unstructured":"Zhao YT, Wang J, Yano N, Zhang LX, Wang H, Zhang S, et al. Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart. J Cell Physiol. 2019;234:1671\u201381.","journal-title":"J Cell Physiol"},{"key":"557_CR74","first-page":"28","volume":"20","author":"F Agh","year":"2017","unstructured":"Agh F, Mohammadzadeh HN, Djalali M, Nematipour E, Gholamhoseini S, Zarei M, et al. Omega-3 fatty acid could increase one of myokines in male patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2017;20:28\u201333.","journal-title":"Arch Iran Med"},{"key":"557_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5830\/CVJA-2017-025","volume":"28","author":"S Aydin","year":"2017","unstructured":"Aydin S, Kuloglu T, Aydin S, Yardim M, Azboy D, Temizturk Z, et al. The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels. Cardiovasc J Afr. 2017;28:389\u201396.","journal-title":"Cardiovasc J Afr"},{"key":"557_CR76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41569-019-0221-2","volume":"16","author":"N Herring","year":"2019","unstructured":"Herring N, Kalla M, Paterson DJ. The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies. Nat Rev Cardiol. 2019;16:707\u201326.","journal-title":"Nat Rev Cardiol"},{"key":"557_CR77","doi-asserted-by":"publisher","first-page":"e181461","DOI":"10.1371\/journal.pone.0181461","volume":"12","author":"L Sundarrajan","year":"2017","unstructured":"Sundarrajan L, Yeung C, Hahn L, Weber LP, Unniappan S. Irisin regulates cardiac physiology in zebrafish. PLoS One. 2017;12:e181461.","journal-title":"PLoS One"},{"key":"557_CR78","first-page":"e136816","volume":"10","author":"C Xie","year":"2015","unstructured":"Xie C, Zhang Y, Tran TD, Wang H, Li S, George EV, et al. Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One. 2015;10:e136816.","journal-title":"PLoS One"},{"key":"557_CR79","doi-asserted-by":"publisher","first-page":"e12419","DOI":"10.14814\/phy2.12419","volume":"3","author":"E Brailoiu","year":"2015","unstructured":"Brailoiu E, Deliu E, Sporici RA, Brailoiu GC. Irisin evokes bradycardia by activating cardiac-projecting neurons of nucleus ambiguus. Physiol Rep. 2015;3:e12419.","journal-title":"Physiol Rep"},{"key":"557_CR80","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","volume":"113","author":"K Nishida","year":"2017","unstructured":"Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017;113:389\u201398.","journal-title":"Cardiovasc Res"},{"key":"557_CR81","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","volume":"60","author":"ZG Ma","year":"2017","unstructured":"Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, et al. CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia. 2017;60:1126\u201337.","journal-title":"Diabetologia."},{"key":"557_CR82","doi-asserted-by":"crossref","first-page":"6053727","DOI":"10.1155\/2018\/6053727","volume":"2018","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Kong CY, Song P, Zhang X, Yuan YP, Tang QZ. Geniposide protects against obesity-related cardiac injury through AMPKalpha- and Sirt1-dependent mechanisms. Oxid Med Cell Longev. 2018;2018:6053727.","journal-title":"Oxid Med Cell Longev"},{"key":"557_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","volume":"417","author":"N Zhang","year":"2016","unstructured":"Zhang N, Yang Z, Xiang SZ, Jin YG, Wei WY, Bian ZY, et al. Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy. Mol Cell Biochem. 2016;417:87\u201396.","journal-title":"Mol Cell Biochem"},{"key":"557_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12020-018-1550-3","volume":"61","author":"T Stratigou","year":"2018","unstructured":"Stratigou T, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Christodoulatos GS, et al. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors. Endocrine. 2018;61:83\u201393.","journal-title":"Endocrine."},{"key":"557_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1857-8","volume":"17","author":"Z Geng","year":"2019","unstructured":"Geng Z, Fan WY, Zhou B, Ye C, Tong Y, Zhou YB, et al. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2\/STAT3-associated inflammation and oxidative stress. J Transl Med. 2019;17:107.","journal-title":"J Transl Med"},{"key":"557_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/JME-19-0123","volume":"63","author":"I Moscoso","year":"2019","unstructured":"Moscoso I, Cebro-Marquez M, Rodriguez-Manero M, Gonzalez-Juanatey JR, Lage R. FNDC5\/Irisin counteracts lipotoxic-induced apoptosis in hypoxic H9c2 cells. J Mol Endocrinol. 2019;63:151\u20139.","journal-title":"J Mol Endocrinol"},{"key":"557_CR87","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14:1645\u201357.","journal-title":"Int J Biol Sci"},{"key":"557_CR88","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.bbadis.2015.08.013","volume":"1852","author":"Y Liu","year":"2015","unstructured":"Liu Y, Hu ZF, Liao HH, Liu W, Liu J, Ma ZG, et al. Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition. Biochim Biophys Acta. 2015;1852:2456\u201366.","journal-title":"Biochim Biophys Acta"},{"key":"557_CR89","doi-asserted-by":"publisher","first-page":"2647129","DOI":"10.1155\/2017\/2647129","volume":"2017","author":"YG Jin","year":"2017","unstructured":"Jin YG, Yuan Y, Wu QQ, Zhang N, Fan D, Che Y, et al. Puerarin protects against cardiac fibrosis associated with the inhibition of TGF-\u03b21\/Smad2-mediated endothelial-to-mesenchymal transition. PPAR Res. 2017;2017:2647129.","journal-title":"PPAR Res"},{"key":"557_CR90","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jcmm.13360","volume":"22","author":"X Liu","year":"2018","unstructured":"Liu X, Mujahid H, Rong B, Lu QH, Zhang W, Li P, et al. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy. J Cell Mol Med. 2018;22:808\u201322.","journal-title":"J Cell Mol Med"},{"key":"557_CR91","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.bbadis.2018.02.012","volume":"1864","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Wu QQ, Duan MX, Liu C, Yuan Y, Yang Z, et al. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1728\u201343.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"557_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2316-4","volume":"11","author":"QQ Wu","year":"2020","unstructured":"Wu QQ, Liu C, Cai ZL, Xie QW, Hu TT, Duan MX, et al. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition. Cell Death Dis. 2020;11:160.","journal-title":"Cell Death Dis"},{"key":"557_CR93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","volume":"16","author":"N Gonzalez","year":"2017","unstructured":"Gonzalez N, Moreno-Villegas Z, Gonzalez-Bris A, Egido J, Lorenzo O. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16:44.","journal-title":"Cardiovasc Diabetol"},{"key":"557_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2261-14-3","volume":"14","author":"HE Park","year":"2014","unstructured":"Park HE, Choi SY, Kim M. Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2-dimensional echocardiography. BMC Cardiovasc Disord. 2014;14:3.","journal-title":"BMC Cardiovasc Disord"},{"key":"557_CR95","doi-asserted-by":"publisher","first-page":"e7372","DOI":"10.1161\/CIRCIMAGING.117.007372","volume":"11","author":"A Ng","year":"2018","unstructured":"Ng A, Strudwick M, van der Geest RJ, Ng A, Gillinder L, Goo SY, et al. Impact of epicardial adipose tissue, left ventricular myocardial fat content, and interstitial fibrosis on myocardial contractile function. Circ Cardiovasc Imaging. 2018;11:e7372.","journal-title":"Circ Cardiovasc Imaging"},{"key":"557_CR96","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/1354750X.2018.1485056","volume":"23","author":"M Sahin","year":"2018","unstructured":"Sahin M, Canpolat AG, Corapcioglu D, Canpolat U, Emral R, Uysal AR. Association between circulating irisin levels and epicardial fat in patients with treatment-naive overt hyperthyroidism. Biomarkers. 2018;23:742\u20137.","journal-title":"Biomarkers."},{"key":"557_CR97","doi-asserted-by":"publisher","first-page":"e201499","DOI":"10.1371\/journal.pone.0201499","volume":"13","author":"H Kaneda","year":"2018","unstructured":"Kaneda H, Nakajima T, Haruyama A, Shibasaki I, Hasegawa T, Sawaguchi T, et al. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients. PLoS One. 2018;13:e201499.","journal-title":"PLoS One"},{"key":"557_CR98","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/CS20171167","volume":"131","author":"QQ Wu","year":"2017","unstructured":"Wu QQ, Xiao Y, Yuan Y, Ma ZG, Liao HH, Liu C, et al. Mechanisms contributing to cardiac remodelling. Clin Sci. 2017;131:2319\u201345.","journal-title":"Clin Sci"},{"key":"557_CR99","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/cvr\/cvy279","volume":"115","author":"ZG Ma","year":"2019","unstructured":"Ma ZG, Yuan YP, Zhang X, Xu SC, Kong CY, Song P, et al. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovasc Res. 2019;115:1067\u201377.","journal-title":"Cardiovasc Res"},{"key":"557_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-018-0678-x","volume":"113","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Dai J, Yuan YP, Bian ZY, Xu SC, Jin YG, et al. T-bet deficiency attenuates cardiac remodelling in rats. Basic Res Cardiol. 2018;113:19.","journal-title":"Basic Res Cardiol"},{"key":"557_CR101","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/CS20180160","volume":"132","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Zhang X, Yuan YP, Jin YG, Li N, Kong CY, et al. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice. Clin Sci. 2018;132:685\u201399.","journal-title":"Clin Sci"},{"key":"557_CR102","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.116.07906","volume":"68","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Yan L, Wu QQ, Zhou H, Jin YG, Bian ZY, et al. Mnk1 (Mitogen-activated protein kinase-interacting kinase 1) deficiency aggravates cardiac remodeling in mice. Hypertension. 2016;68:1393\u20139.","journal-title":"Hypertension."},{"key":"557_CR103","doi-asserted-by":"publisher","unstructured":"Zhang X, Hu C, Zhang N, Wei WY, Li LL, Wu HM, et al. Matrine attenuates pathological cardiac fibrosis via RPS5\/p38 in mice. Acta Pharmacol Sin. 2020;41: in press. https:\/\/doi.org\/10.1038\/s41401-020-0473-8.","DOI":"10.1038\/s41401-020-0473-8"},{"key":"557_CR104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbi.2019.01.031","volume":"302","author":"RR Chen","year":"2019","unstructured":"Chen RR, Fan XH, Chen G, Zeng GW, Xue YG, Liu XT, et al. Irisin attenuates angiotensin II-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS\/TGF-\u03b21\/Smad2\/3 signaling axis. Chem Biol Interact. 2019;302:11\u201321.","journal-title":"Chem Biol Interact"},{"key":"557_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/cvr\/cvr159","volume":"92","author":"L Yan","year":"2011","unstructured":"Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, et al. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT\/GSK3\u03b2 and TGF-\u03b21-Smad signalling. Cardiovasc Res. 2011;92:85\u201394.","journal-title":"Cardiovasc Res"},{"key":"557_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0123-3","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ma ZG, Yuan YP, Xu SC, Wei WY, Song P, et al. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPK\u03b1\/Smad3 signaling. Cell Death Dis. 2018;9:102.","journal-title":"Cell Death Dis"},{"key":"557_CR107","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1074\/jbc.M114.617399","volume":"290","author":"JP Tiano","year":"2015","unstructured":"Tiano JP, Springer DA, Rane SG. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor \u03b3 coactivator 1-\u03b1 (PGC-1\u03b1) during exercise. J Biol Chem. 2015;290:7671\u201384.","journal-title":"J Biol Chem"},{"key":"557_CR108","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbrc.2019.10.077","volume":"520","author":"Q Guo","year":"2019","unstructured":"Guo Q, Wei XJ, Hu HL, Yang DQ, Zhang BY, Fan XP, et al. The saturated fatty acid palmitate induces insulin resistance through Smad3-mediated down-regulation of FNDC5 in myotubes. Biochem Biophys Res Commun. 2019;520:619\u201326.","journal-title":"Biochem Biophys Res Commun"},{"key":"557_CR109","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/CS20190016","volume":"133","author":"Q Yu","year":"2019","unstructured":"Yu Q, Kou W, Xu X, Zhou S, Luan P, Xu X, et al. FNDC5\/Irisin inhibits pathological cardiac hypertrophy. Clin Sci. 2019;133:611\u201327.","journal-title":"Clin Sci"},{"key":"557_CR110","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ejhf.1629","volume":"21","author":"G Hao","year":"2019","unstructured":"Hao G, Wang X, Chen Z, Zhang LF, Zhang YH, Wei BQ, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail. 2019;21:1329\u201337.","journal-title":"Eur J Heart Fail"},{"key":"557_CR111","doi-asserted-by":"publisher","first-page":"e210320","DOI":"10.1371\/journal.pone.0210320","volume":"14","author":"A Silvestrini","year":"2019","unstructured":"Silvestrini A, Bruno C, Vergani E, Venuti A, Favuzzi A, Guidi F, et al. Circulating irisin levels in heart failure with preserved or reduced ejection fraction: a pilot study. PLoS One. 2019;14:e210320.","journal-title":"PLoS One"},{"key":"557_CR112","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jcsm.12006","volume":"6","author":"Y Matsuo","year":"2015","unstructured":"Matsuo Y, Gleitsmann K, Mangner N, Werner S, Fischer T, Bowen TS, et al. Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines. J Cachexia Sarcopenia Muscle. 2015;6:62\u201372.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"557_CR113","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1159\/000485925","volume":"42","author":"SJ Zhou","year":"2017","unstructured":"Zhou SJ, Han QF, Zhang AH, Tang W, Sun LH. Irisin and volume overload are associated with protein energy wasting in peritoneal dialysis patients. Kidney Blood Press Res. 2017;42:1216\u201324.","journal-title":"Kidney Blood Press Res"},{"key":"557_CR114","first-page":"39","volume":"111","author":"AK Kalkan","year":"2018","unstructured":"Kalkan AK, Cakmak HA, Erturk M, Kalkan KE, Uzun F, Tasbulak O, et al. Adropin and irisin in patients with cardiac cachexia. Arq Bras Cardiol. 2018;111:39\u201347.","journal-title":"Arq Bras Cardiol"},{"key":"557_CR115","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1159\/000477867","volume":"42","author":"S Shen","year":"2017","unstructured":"Shen S, Gao R, Bei Y, Li J, Zhang H, Zhou Y, et al. Serum irisin predicts mortality risk in acute heart failure patients. Cell Physiol Biochem. 2017;42:615\u201322.","journal-title":"Cell Physiol Biochem"},{"key":"557_CR116","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/CIRCHEARTFAILURE.112.969543","volume":"5","author":"SH Lecker","year":"2012","unstructured":"Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM, et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail. 2012;5:812\u20138.","journal-title":"Circ Heart Fail"},{"key":"557_CR117","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res. 2020;126:926\u201341.","journal-title":"Circ Res"},{"key":"557_CR118","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.10.008","volume":"114","author":"YP Yuan","year":"2018","unstructured":"Yuan YP, Ma ZG, Zhang X, Xu SC, Zeng XF, Yang Z, et al. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2018;114:38\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"557_CR119","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7150\/ijbs.29907","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhu JX, Ma ZG, Wu HM, Xu SC, Song P, et al. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2019;15:556\u201367.","journal-title":"Int J Biol Sci"},{"key":"557_CR120","volume":"10","author":"C Hu","year":"2020","unstructured":"Hu C, Zhang X, Zhang N, Wei WY, Li LL, Ma ZG, et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020;10:e124.","journal-title":"Clin Transl Med"},{"key":"557_CR121","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.redox.2020.101747","volume":"37","author":"C Hu","year":"2020","unstructured":"Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, et al. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway. Redox Biol. 2020;37:101747.","journal-title":"Redox Biol"},{"key":"557_CR122","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/10520295.2014.977949","volume":"90","author":"S Aydin","year":"2015","unstructured":"Aydin S, Eren MN, Kuloglu T, Aydin S, Yilmaz M, Gul E, et al. Alteration of serum and cardiac tissue adropin, copeptin, irisin and TRPM2 expressions in DOX treated male rats. Biotech Histochem. 2015;90:197\u2013205.","journal-title":"Biotech Histochem"},{"key":"557_CR123","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","volume":"116","author":"MW Merx","year":"2007","unstructured":"Merx MW, Weber C. Sepsis and the heart. Circulation. 2007;116:793\u2013802.","journal-title":"Circulation."},{"key":"557_CR124","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2020.02.011","volume":"152","author":"P Song","year":"2020","unstructured":"Song P, Shen DF, Meng YY, Kong CY, Zhang X, Yuan YP, et al. Geniposide protects against sepsis-induced myocardial dysfunction through AMPK\u03b1-dependent pathway. Free Radic Biol Med. 2020;152:186\u201396.","journal-title":"Free Radic Biol Med"},{"key":"557_CR125","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.redox.2019.101215","volume":"24","author":"N Li","year":"2019","unstructured":"Li N, Zhou H, Wu HM, Wu QQ, Duan MX, Deng W, et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019;24:101215.","journal-title":"Redox Biol"},{"key":"557_CR126","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2018.04.006","volume":"476","author":"WY Wei","year":"2018","unstructured":"Wei WY, Ma ZG, Zhang N, Xu SC, Yuan YP, Zeng XF, et al. Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in mice. Mol Cell Endocrinol. 2018;476:27\u201336.","journal-title":"Mol Cell Endocrinol"},{"key":"557_CR127","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12192-019-00992-2","volume":"24","author":"Y Tan","year":"2019","unstructured":"Tan Y, Ouyang HC, Xiao XC, Zhong JK, Dong ML. Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway. Cell Stress Chaperones. 2019;24:595\u2013608.","journal-title":"Cell Stress Chaperones"},{"key":"557_CR128","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1590\/2359-3997000000305","volume":"61","author":"I Bonfante","year":"2017","unstructured":"Bonfante I, Chacon-Mikahil M, Brunelli DT, Gaspari AF, Duft RG, Oliveira AG, et al. Obese with higher FNDC5\/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk. Arch Endocrinol Metab. 2017;61:524\u201333.","journal-title":"Arch Endocrinol Metab"},{"key":"557_CR129","doi-asserted-by":"publisher","first-page":"347","DOI":"10.17219\/acem\/81538","volume":"28","author":"M Kaluzna","year":"2019","unstructured":"Kaluzna M, Pawlaczyk K, Schwermer K, Hoppe K, Czlapka-Matyasik M, Ibrahim AY, et al. Adropin and irisin: new biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study. Adv Clin Exp Med. 2019;28:347\u201353.","journal-title":"Adv Clin Exp Med"},{"key":"557_CR130","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.11.008","volume":"139","author":"C Hu","year":"2019","unstructured":"Hu C, Jia WP. Therapeutic medications against diabetes: what we have and what we expect. Adv Drug Deliv Rev. 2019;139:3\u201315.","journal-title":"Adv Drug Deliv Rev"},{"key":"557_CR131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0004563215582072","volume":"53","author":"WC Hu","year":"2016","unstructured":"Hu WC, Wang R, Li J, Zhang J, Wang WH. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy. Ann Clin Biochem. 2016;53:67\u201374.","journal-title":"Ann Clin Biochem"},{"key":"557_CR132","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/10641963.2018.1529779","volume":"41","author":"BX Li","year":"2019","unstructured":"Li BX, Yao Q, Guo SQ, Ma S, Dong YH, Xin HH, et al. Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5. Clin Exp Hypertens. 2019;41:645\u201350.","journal-title":"Clin Exp Hypertens"},{"key":"557_CR133","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.clinbiochem.2015.07.098","volume":"48","author":"ID Duran","year":"2015","unstructured":"Duran ID, Gulcelik NE, Unal M, Topcuoglu C, Sezer S, Tuna MM, et al. Irisin levels in the progression of diabetes in sedentary women. Clin Biochem. 2015;48:1268\u201372.","journal-title":"Clin Biochem"},{"key":"557_CR134","first-page":"2616539","volume":"2016","author":"LS Wang","year":"2016","unstructured":"Wang LS, Song J, Wang C, Lin P, Liang K, Sun Y, et al. Circulating levels of betatrophin and irisin are not associated with pancreatic \u03b2-cell function in previously diagnosed type 2 diabetes mellitus patients. J Diabetes Res. 2016;2016:2616539.","journal-title":"J Diabetes Res"},{"key":"557_CR135","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.diabres.2013.01.007","volume":"100","author":"YK Choi","year":"2013","unstructured":"Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pr. 2013;100:96\u2013101.","journal-title":"Diabetes Res Clin Pr"},{"key":"557_CR136","doi-asserted-by":"crossref","unstructured":"Guilford BL, Parson JC, Grote CW, Vick SN, Ryals JM, Wright DE. Increased FNDC5 is associated with insulin resistance in high fat-fed mice. Physiol Rep. 2017;5:e13319.","DOI":"10.14814\/phy2.13319"},{"key":"557_CR137","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12944-016-0224-5","volume":"15","author":"NM Al-Daghri","year":"2016","unstructured":"Al-Daghri NM, Mohammed AK, Al-Attas OS, Amer OE, Clerici M, Alenad A, et al. SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects. Lipids Health Dis. 2016;15:54.","journal-title":"Lipids Health Dis"},{"key":"557_CR138","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12020-015-0758-8","volume":"52","author":"B Garcia-Fontana","year":"2016","unstructured":"Garcia-Fontana B, Reyes-Garcia R, Morales-Santana S, Avila-Rubio V, Munoz-Garach A, Rozas-Moreno P, et al. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state? Endocrine. 2016;52:54\u201362.","journal-title":"Endocrine."},{"key":"557_CR139","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/dme.12731","volume":"32","author":"D Espes","year":"2015","unstructured":"Espes D, Lau J, Carlsson PO. Increased levels of irisin in people with long-standing type 1 diabetes. Diabet Med. 2015;32:1172\u20136.","journal-title":"Diabet Med"},{"key":"557_CR140","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.diabres.2018.03.046","volume":"141","author":"MF Faienza","year":"2018","unstructured":"Faienza MF, Brunetti G, Sanesi L, Colaianni G, Celi M, Piacente L, et al. High irisin levels are associated with better glycemic control and bone health in children with type 1 diabetes. Diabetes Res Clin Pr. 2018;141:10\u20137.","journal-title":"Diabetes Res Clin Pr"},{"key":"557_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/enr-2017-0001","volume":"51","author":"I Ates","year":"2017","unstructured":"Ates I, Arikan MF, Erdogan K, Kaplan M, Yuksel M, Topcuoglu C, et al. Factors associated with increased irisin levels in the type 1 diabetes mellitus. Endocr Regul. 2017;51:1\u20137.","journal-title":"Endocr Regul"},{"key":"557_CR142","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12020-014-0170-9","volume":"46","author":"F Sanchis-Gomar","year":"2014","unstructured":"Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor VM, Rocha M, et al. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine. 2014;46:674\u20137.","journal-title":"Endocrine."},{"key":"557_CR143","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1507\/endocrj.EJ16-0249","volume":"63","author":"A Adamska","year":"2016","unstructured":"Adamska A, Karczewska-Kupczewska M, Lebkowska A, Milewski R, Gorska M, Otziomek E, et al. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome. Endocr J. 2016;63:1107\u201312.","journal-title":"Endocr J"},{"key":"557_CR144","first-page":"881","volume":"63","author":"BW Liu","year":"2017","unstructured":"Liu BW, Yin FZ, Qi XM, Fan DM, Zhang Y. The levels of serum irisin as a predictor of insulin resistance in Han Chinese adults with metabolically healthy obesity. Clin Lab. 2017;63:881\u20136.","journal-title":"Clin Lab"},{"key":"557_CR145","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1055\/s-0042-116155","volume":"48","author":"M Belviranli","year":"2016","unstructured":"Belviranli M, Okudan N, Celik F. Association of circulating irisin with insulin resistance and oxidative stress in obese women. Horm Metab Res. 2016;48:653\u20137.","journal-title":"Horm Metab Res"},{"key":"557_CR146","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1159\/000495395","volume":"51","author":"D Zhang","year":"2018","unstructured":"Zhang D, Xie T, Leung PS. Irisin ameliorates glucolipotoxicity-associated \u03b2-cell dysfunction and apoptosis via AMPK signaling and anti-inflammatory actions. Cell Physiol Biochem. 2018;51:924\u201337.","journal-title":"Cell Physiol Biochem"},{"key":"557_CR147","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijbiomac.2015.12.049","volume":"84","author":"HK Duan","year":"2016","unstructured":"Duan HK, Ma BC, Ma XF, Wang HS, Ni ZZ, Wang B, et al. Anti-diabetic activity of recombinant irisin in STZ-induced insulin-deficient diabetic mice. Int J Biol Macromol. 2016;84:457\u201363.","journal-title":"Int J Biol Macromol"},{"key":"557_CR148","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1758-5996-6-133","volume":"6","author":"ML Yang","year":"2014","unstructured":"Yang ML, Chen PH, Jin H, Xie XM, Gao T, Yang LL, et al. Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus-correlation with pancreatic \u03b2-cell function. Diabetol Metab Syndr. 2014;6:133.","journal-title":"Diabetol Metab Syndr"},{"key":"557_CR149","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexcr.2017.09.006","volume":"360","author":"YL Pang","year":"2017","unstructured":"Pang YL, Zhu HH, Xu JQ, Yang LH, Liu LJ, Li J. \u03b2-arrestin-2 is involved in irisin induced glucose metabolism in type 2 diabetes via p38 MAPK signaling. Exp Cell Res. 2017;360:199\u2013204.","journal-title":"Exp Cell Res"},{"key":"557_CR150","doi-asserted-by":"publisher","first-page":"E2154","DOI":"10.1210\/jc.2014-1437","volume":"99","author":"JY Huh","year":"2014","unstructured":"Huh JY, Mougios V, Kabasakalis A, Fatouros I, Siopi A, Douroudos II. et al. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab. 2014;99:E2154\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR151","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/ijo.2014.42","volume":"38","author":"JY Huh","year":"2014","unstructured":"Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes. 2014;38:1538\u201344.","journal-title":"Int J Obes"},{"key":"557_CR152","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/me.2014-1353","volume":"29","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Lee JO, Kim N, Kim JK, Kim HI, Lee YW, et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol. 2015;29:873\u201381.","journal-title":"Mol Endocrinol"},{"key":"557_CR153","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ijo.2015.199","volume":"40","author":"C Xin","year":"2016","unstructured":"Xin C, Liu JY, Zhang JL, Zhu D, Wang HC, Xiong LZ, et al. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int J Obes. 2016;40:443\u201351.","journal-title":"Int J Obes"},{"key":"557_CR154","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2018.05.013","volume":"114","author":"DD Zhang","year":"2018","unstructured":"Zhang DD, Bae C, Lee J, Lee J, Jin ZY, Kang M, et al. The bone anabolic effects of irisin are through preferential stimulation of aerobic glycolysis. Bone. 2018;114:150\u201360.","journal-title":"Bone."},{"key":"557_CR155","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/CS20150009","volume":"129","author":"TY Liu","year":"2015","unstructured":"Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K\/Akt pathway in type 2 diabetic mice and hepatocytes. Clin Sci. 2015;129:839\u201350.","journal-title":"Clin Sci"},{"key":"557_CR156","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4161\/adip.27370","volume":"3","author":"F Sanchis-Gomar","year":"2014","unstructured":"Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1\u03b1-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte. 2014;3:67\u20138.","journal-title":"Adipocyte."},{"key":"557_CR157","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/eci.12324","volume":"44","author":"C Gutierrez-Repiso","year":"2014","unstructured":"Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Garcia-Escobar E, Haro-Mora JJ, Garcia-Arnes J, et al. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest. 2014;44:918\u201325.","journal-title":"Eur J Clin Invest"},{"key":"557_CR158","doi-asserted-by":"publisher","first-page":"154924","DOI":"10.1016\/j.cyto.2019.154924","volume":"126","author":"LL Cui","year":"2020","unstructured":"Cui LL, Qiao TY, Xu F, Li ZL, Chen TT, Su HL, et al. Circulating irisin levels of prenatal and postnatal patients with gestational diabetes mellitus: a systematic review and meta-analysis. Cytokine. 2020;126:154924.","journal-title":"Cytokine."},{"key":"557_CR159","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cyto.2013.11.009","volume":"65","author":"T Ebert","year":"2014","unstructured":"Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine. 2014;65:153\u20138.","journal-title":"Cytokine."},{"key":"557_CR160","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.peptides.2013.07.001","volume":"47","author":"S Aydin","year":"2013","unstructured":"Aydin S, Kuloglu T, Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides. 2013;47:66\u201370.","journal-title":"Peptides"},{"key":"557_CR161","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.diabres.2013.12.025","volume":"104","author":"MA Yuksel","year":"2014","unstructured":"Yuksel MA, Oncul M, Tuten A, Imamoglu M, Acikgoz AS, Kucur M, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pr. 2014;104:171\u20135.","journal-title":"Diabetes Res Clin Pr"},{"key":"557_CR162","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1507\/endocrj.EJ15-0230","volume":"62","author":"L Zhao","year":"2015","unstructured":"Zhao L, Li J, Li ZL, Yang J, Li ML, Wang GL. Circulating irisin is lower in gestational diabetes mellitus. Endocr J. 2015;62:921\u20136.","journal-title":"Endocr J"},{"key":"557_CR163","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/09513590.2014.920006","volume":"30","author":"M Kuzmicki","year":"2014","unstructured":"Kuzmicki M, Telejko B, Lipinska D, Pliszka J, Szamatowicz M, Wilk J, et al. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol. 2014;30:636\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"557_CR164","first-page":"3429","volume":"29","author":"DD Briana","year":"2016","unstructured":"Briana DD, Boutsikou M, Athanasopoulos N, Marmarinos A, Gourgiotis D, Malamitsi-Puchner A. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth. J Matern Fetal Neonatal Med. 2016;29:3429\u201333.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"557_CR165","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1210\/jc.2013-4127","volume":"99","author":"MF Garces","year":"2014","unstructured":"Garces MF, Peralta JJ, Ruiz-Linares CE, Lozano AR, Poveda NE, Torres-Sierra AL, et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab. 2014;99:2113\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR166","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.diabres.2018.05.038","volume":"142","author":"P Wang","year":"2018","unstructured":"Wang P, Ma HH, Hou XZ, Song LL, Song XL, Zhang JF. Reduced plasma level of irisin in first trimester as a risk factor for the development of gestational diabetes mellitus. Diabetes Res Clin Pr. 2018;142:130\u20138.","journal-title":"Diabetes Res Clin Pr"},{"key":"557_CR167","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.3109\/14767058.2016.1142967","volume":"29","author":"O Erol","year":"2016","unstructured":"Erol O, Erkal N, Ellidag HY, Isenlik BS, Aydin O, Derbent AU, et al. Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study. J Matern Fetal Neonatal Med. 2016;29:3590\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"557_CR168","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"557_CR169","doi-asserted-by":"publisher","first-page":"E2539","DOI":"10.1210\/jc.2014-1180","volume":"99","author":"CL Chang","year":"2014","unstructured":"Chang CL, Huang SY, Soong YK, Cheng PJ, Wang CJ, Liang IT. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99:E2539\u201348.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR170","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"Li H, Xu X, Wang X, Liao X, Li L, Yang G, et al. Free androgen index and Irisin in polycystic ovary syndrome. J Endocrinol Invest. 2016;39:549\u201356.","journal-title":"J Endocrinol Invest"},{"key":"557_CR171","first-page":"4462","volume":"19","author":"MS Bostanci","year":"2015","unstructured":"Bostanci MS, Akdemir N, Cinemre B, Cevrioglu AS, Ozden S, Unal O. Serum irisin levels in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2015;19:4462\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"557_CR172","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/cen.13555","volume":"88","author":"F Bacopoulou","year":"2018","unstructured":"Bacopoulou F, Athanasopoulos N, Efthymiou V, Mantzou A, Aravantinos L, Vlahopoulos S, et al. Serum irisin concentrations in lean adolescents with polycystic ovary syndrome. Clin Endocrinol. 2018;88:585\u201391.","journal-title":"Clin Endocrinol"},{"key":"557_CR173","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1210\/jc.2014-2544","volume":"100","author":"MY Li","year":"2015","unstructured":"Li MY, Yang ML, Zhou XX, Fang X, Hu WJ, Zhu W, et al. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100:1485\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR174","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/01443615.2016.1174200","volume":"36","author":"R Abali","year":"2016","unstructured":"Abali R, Temel YI, Yuksel MA, Bulut B, Imamoglu M, Emirdar V, et al. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome. J Obstet Gynaecol. 2016;36:897\u2013901.","journal-title":"J Obstet Gynaecol"},{"key":"557_CR175","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/cen.13805","volume":"89","author":"W Wang","year":"2018","unstructured":"Wang W, Guo Y, Zhang XX, Zheng JH. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients. Clin Endocrinol. 2018;89:474\u201380.","journal-title":"Clin Endocrinol"},{"key":"557_CR176","first-page":"89","volume":"19","author":"S Bakhshalizadeh","year":"2018","unstructured":"Bakhshalizadeh S, Rabiee F, Shirazi R, Ghaedi K, Amidi F, Nasr-Esfahani MH. Assessment of PGC1\u03b1-FNDC5 axis in granulosa cells of PCOS mouse model. J Reprod Infertil. 2018;19:89\u201394.","journal-title":"J Reprod Infertil"},{"key":"557_CR177","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3109\/09513590.2015.1065482","volume":"31","author":"K Pukajlo","year":"2015","unstructured":"Pukajlo K, Laczmanski L, Kolackov K, Kuliczkowska-Plaksej J, Bolanowski M, Milewicz A, et al. Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution. Gynecol Endocrinol. 2015;31:907\u201311.","journal-title":"Gynecol Endocrinol"},{"key":"557_CR178","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/09513590.2018.1529158","volume":"35","author":"C Li","year":"2019","unstructured":"Li C, Zhou L, Xie Y, Guan C, Gao H. Effect of irisin on endometrial receptivity of rats with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35:395\u2013400.","journal-title":"Gynecol Endocrinol"},{"key":"557_CR179","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/dmrr.2767","volume":"32","author":"S Gao","year":"2016","unstructured":"Gao S, Cheng Y, Zhao L, Chen Y, Liu Y. The relationships of irisin with bone mineral density and body composition in PCOS patients. Diabetes Metab Res Rev. 2016;32:421\u20138.","journal-title":"Diabetes Metab Res Rev"},{"key":"557_CR180","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gene.2017.05.010","volume":"626","author":"EG Khidr","year":"2017","unstructured":"Khidr EG, Ali SS, Elshafey MM, Fawzy OA. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study. Gene. 2017;626:26\u201331.","journal-title":"Gene."},{"key":"557_CR181","doi-asserted-by":"publisher","first-page":"e61903","DOI":"10.1371\/journal.pone.0061903","volume":"8","author":"H Staiger","year":"2013","unstructured":"Staiger H, Bohm A, Scheler M, Berti L, Machann J, Schick F, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived \u2018browning\u2019 factor irisin, determines insulin sensitivity. PLoS One. 2013;8:e61903.","journal-title":"PLoS One"},{"key":"557_CR182","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.metabol.2014.01.005","volume":"63","author":"K Tanisawa","year":"2014","unstructured":"Tanisawa K, Taniguchi H, Sun X, Ito T, Cao ZB, Sakamoto S, et al. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels. Metabolism. 2014;63:574\u201383.","journal-title":"Metabolism."},{"key":"557_CR183","doi-asserted-by":"publisher","first-page":"e109957","DOI":"10.1371\/journal.pone.0109957","volume":"9","author":"SS Tang","year":"2014","unstructured":"Tang SS, Zhang R, Jiang F, Wang J, Chen M, Peng DF, et al. An interaction between a FNDC5 variant and obesity modulates glucose metabolism in a Chinese Han population. PLoS One. 2014;9:e109957.","journal-title":"PLoS One"},{"key":"557_CR184","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ijo.2015.157","volume":"40","author":"T Ebert","year":"2016","unstructured":"Ebert T, Kralisch S, Wurst U, Scholz M, Stumvoll M, Kovacs P, et al. Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations. Int J Obes. 2016;40:260\u20135.","journal-title":"Int J Obes"},{"key":"557_CR185","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/1440-1681.12566","volume":"43","author":"SS Tang","year":"2016","unstructured":"Tang SS, Zhang R, Jiang F, Wang J, Chen M, Peng DF, et al. Association between FNDC5 genetic variants and proliferative diabetic retinopathy in a Chinese population. Clin Exp Pharmacol Physiol. 2016;43:580\u20132.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"557_CR186","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1152\/physrev.00034.2018","volume":"99","author":"SN Saxton","year":"2019","unstructured":"Saxton SN, Clark BJ, Withers SB, Eringa EC, Heagerty AM. Mechanistic links between obesity, diabetes, and blood pressure: role of perivascular adipose tissue. Physiol Rev. 2019;99:1701\u201363.","journal-title":"Physiol Rev"},{"key":"557_CR187","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.peptides.2014.09.014","volume":"61","author":"S Aydin","year":"2014","unstructured":"Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Cakmak T, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014;61:130\u20136.","journal-title":"Peptides."},{"key":"557_CR188","doi-asserted-by":"publisher","first-page":"180416","DOI":"10.7754\/Clin.Lab.2018.180416","volume":"64","author":"W Gouda","year":"2018","unstructured":"Gouda W, Mageed L, Shaker Y, Hamimy WI, Afify M. Assessment of serum vitamin D and irisin levels in obese patients. Clin Lab. 2018;64:180416.","journal-title":"Clin Lab"},{"key":"557_CR189","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diabet.2018.08.003","volume":"45","author":"F Bensmaine","year":"2019","unstructured":"Bensmaine F, Benomar K, Espiard S, Vahe C, Le Mapihan K, Lion G, et al. Irisin levels in LMNA-associated partial lipodystrophies. Diabetes Metab. 2019;45:67\u201375.","journal-title":"Diabetes Metab"},{"key":"557_CR190","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1139\/apnm-2017-0614","volume":"43","author":"F Kazeminasab","year":"2018","unstructured":"Kazeminasab F, Marandi SM, Ghaedi K, Safaeinejad Z, Esfarjani F, Nasr-Esfahani MH. A comparative study on the effects of high-fat diet and endurance training on the PGC-1\u03b1-FNDC5\/Irisin pathway in obese and nonobese male C57BL\/6 mice. Appl Physiol Nutr Metab. 2018;43:651\u201362.","journal-title":"Appl Physiol Nutr Metab"},{"key":"557_CR191","doi-asserted-by":"publisher","first-page":"2628968","DOI":"10.1155\/2017\/2628968","volume":"2017","author":"L Elizondo-Montemayor","year":"2017","unstructured":"Elizondo-Montemayor L, Silva-Platas C, Torres-Quintanilla A, Rodriguez-Lopez C, Ruiz-Esparza GU, Reyes-Mendoza E, et al. Association of irisin plasma levels with anthropometric parameters in children with underweight, normal weight, overweight, and obesity. Biomed Res Int. 2017;2017:2628968.","journal-title":"Biomed Res Int"},{"key":"557_CR192","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4274\/jcrpe.3963","volume":"9","author":"C Binay","year":"2017","unstructured":"Binay C, Paketci C, Guzel S, Samanci N. Serum irisin and oxytocin levels as predictors of metabolic parameters in obese children. J Clin Res Pediatr Endocrinol. 2017;9:124\u201331.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"557_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/srep29898","volume":"6","author":"BM Varela-Rodriguez","year":"2016","unstructured":"Varela-Rodriguez BM, Pena-Bello L, Juiz-Valina P, Vidal-Bretal B, Cordido F, Sangiao-Alvarellos S. FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Sci Rep. 2016;6:29898.","journal-title":"Sci Rep"},{"key":"557_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16602-z","volume":"7","author":"D Perez-Sotelo","year":"2017","unstructured":"Perez-Sotelo D, Roca-Rivada A, Baamonde I, Baltar J, Castro AI, Dominguez E, et al. Lack of adipocyte-Fndc5\/Irisin expression and secretion reduces thermogenesis and enhances adipogenesis. Sci Rep. 2017;7:16289.","journal-title":"Sci Rep"},{"key":"557_CR195","first-page":"e147480","volume":"11","author":"S Gao","year":"2016","unstructured":"Gao S, Li F, Li H, Huang Y, Liu Y, Chen Y. Effects and molecular mechanism of GST-irisin on lipolysis and autocrine function in 3T3-L1 adipocytes. PLoS One. 2016;11:e147480.","journal-title":"PLoS One"},{"key":"557_CR196","doi-asserted-by":"publisher","first-page":"E769","DOI":"10.1210\/jc.2012-2749","volume":"98","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769\u201378.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/srep23067","volume":"6","author":"S Barja-Fernandez","year":"2016","unstructured":"Barja-Fernandez S, Folgueira C, Castelao C, Al-Massadi O, Bravo SB, Garcia-Caballero T, et al. FNDC5 is produced in the stomach and associated to body composition. Sci Rep. 2016;6:23067.","journal-title":"Sci Rep"},{"key":"557_CR198","doi-asserted-by":"publisher","unstructured":"Zhao ZM, Yao MM, Wei L, Ge SJ. Obesity caused by a high-fat diet regulates the Sirt1\/PGC-1\u03b1\/FNDC5\/BDNF pathway to exacerbate isoflurane-induced postoperative cognitive dysfunction in older mice. Nutr Neurosci. 2019;1\u201312.\u00a0https:\/\/doi.org\/10.1080\/1028415X.2019.1581460.","DOI":"10.1080\/1028415X.2019.1581460"},{"key":"557_CR199","doi-asserted-by":"publisher","first-page":"e94235","DOI":"10.1371\/journal.pone.0094235","volume":"9","author":"B Yan","year":"2014","unstructured":"Yan B, Shi XL, Zhang HJ, Pan LL, Ma ZM, Liu SH, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One. 2014;9:e94235.","journal-title":"PLoS One"},{"key":"557_CR200","doi-asserted-by":"publisher","first-page":"8956509","DOI":"10.1155\/2018\/8956509","volume":"2018","author":"W Leung","year":"2018","unstructured":"Leung W, Yu AP, Lai C, Siu PM. Association of markers of proinflammatory phenotype and beige adipogenesis with metabolic syndrome in Chinese centrally obese adults. J Diabetes Res. 2018;2018:8956509.","journal-title":"J Diabetes Res"},{"key":"557_CR201","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.metabol.2017.05.007","volume":"73","author":"HB Jang","year":"2017","unstructured":"Jang HB, Kim HJ, Kang JH, Park SI, Park KH, Lee HJ. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism. 2017;73:100\u20138.","journal-title":"Metabolism."},{"key":"557_CR202","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3803\/EnM.2019.34.2.140","volume":"34","author":"E Eslampour","year":"2019","unstructured":"Eslampour E, Ebrahimzadeh F, Abbasnezhad A, Khosroshahi MZ, Choghakhori R, Asbaghi O. Association between circulating irisin and C-reactive protein levels: a systematic review and meta-analysis. Endocrinol Metab. 2019;34:140\u20139.","journal-title":"Endocrinol Metab"},{"key":"557_CR203","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/oby.21029","volume":"23","author":"B Palacios-Gonzalez","year":"2015","unstructured":"Palacios-Gonzalez B, Vadillo-Ortega F, Polo-Oteyza E, Sanchez T, Ancira-Moreno M, Romero-Hidalgo S, et al. Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity. 2015;23:729\u201332.","journal-title":"Obesity."},{"key":"557_CR204","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.metabol.2014.06.001","volume":"63","author":"G Panagiotou","year":"2014","unstructured":"Panagiotou G, Mu L, Na B, Mukamal KJ, Mantzoros CS. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism. 2014;63:1265\u201371.","journal-title":"Metabolism."},{"key":"557_CR205","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1096\/fj.201801754RR","volume":"33","author":"Y Xiong","year":"2019","unstructured":"Xiong Y, Wu ZH, Zhang B, Wang C, Mao FY, Liu X, et al. Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice. FASEB J. 2019;33:5876\u201386.","journal-title":"FASEB J"},{"key":"557_CR206","doi-asserted-by":"publisher","first-page":"165705","DOI":"10.1016\/j.bbadis.2020.165705","volume":"1866","author":"CM Canivet","year":"2020","unstructured":"Canivet CM, Bonnafous S, Rousseau D, Leclere PS, Lacas-Gervais S, Patouraux S, et al. Hepatic FNDC5 is a potential local protective factor against non-alcoholic fatty liver. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165705.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"557_CR207","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jhep.2013.04.030","volume":"59","author":"HJ Zhang","year":"2013","unstructured":"Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013;59:557\u201362.","journal-title":"J Hepatol"},{"key":"557_CR208","doi-asserted-by":"publisher","first-page":"E530","DOI":"10.1152\/ajpendo.00094.2016","volume":"311","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xie C, Wang H, Foss RM, Clare M, George EV, et al. Irisin exerts dual effects on browning and adipogenesis of human white adipocytes. Am J Physiol Endocrinol Metab. 2016;311:E530\u201341.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"557_CR209","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fphar.2019.00548","volume":"10","author":"H Li","year":"2019","unstructured":"Li H, Shen J, Wu T, Kuang JY, Liu QH, Cheng SH, et al. Irisin is controlled by farnesoid X receptor and regulates cholesterol homeostasis. Front Pharmacol. 2019;10:548.","journal-title":"Front Pharmacol"},{"key":"557_CR210","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmet.2013.12.017","volume":"19","author":"P Lee","year":"2014","unstructured":"Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014;19:302\u20139.","journal-title":"Cell Metab"},{"key":"557_CR211","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2337\/db13-1106","volume":"63","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63:514\u201325.","journal-title":"Diabetes."},{"key":"557_CR212","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.metabol.2018.01.013","volume":"83","author":"XQ Xiong","year":"2018","unstructured":"Xiong XQ, Geng Z, Zhou B, Zhang F, Han Y, Zhou YB, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31\u201341.","journal-title":"Metabolism."},{"key":"557_CR213","doi-asserted-by":"publisher","first-page":"1701035","DOI":"10.1002\/mnfr.201701035","volume":"62","author":"T Xing","year":"2018","unstructured":"Xing T, Kang Y, Xu X, Wang B, Du M, Zhu MJ. Raspberry supplementation improves insulin signaling and promotes brown-like adipocyte development in white adipose tissue of obese mice. Mol Nutr Food Res. 2018;62:1701035.","journal-title":"Mol Nutr Food Res"},{"key":"557_CR214","first-page":"243","volume":"68","author":"AI Mazur-Bialy","year":"2017","unstructured":"Mazur-Bialy AI, Bilski J, Pochec E, Brzozowski T. New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes. J Physiol Pharmacol. 2017;68:243\u201351.","journal-title":"J Physiol Pharmacol"},{"key":"557_CR215","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejphar.2016.09.011","volume":"791","author":"C Ferrante","year":"2016","unstructured":"Ferrante C, Orlando G, Recinella L, Leone S, Chiavaroli A, Di Nisio C, et al. Central inhibitory effects on feeding induced by the adipo-myokine irisin. Eur J Pharmacol. 2016;791:389\u201394.","journal-title":"Eur J Pharmacol"},{"key":"557_CR216","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.peptides.2017.02.003","volume":"90","author":"ZD Butt","year":"2017","unstructured":"Butt ZD, Hackett JD, Volkoff H. Irisin in goldfish (Carassius auratus): effects of irisin injections on feeding behavior and expression of appetite regulators, uncoupling proteins and lipoprotein lipase, and fasting-induced changes in FNDC5 expression. Peptides. 2017;90:27\u201336.","journal-title":"Peptides."},{"key":"557_CR217","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.appet.2015.03.003","volume":"90","author":"M Schlogl","year":"2015","unstructured":"Schlogl M, Piaggi P, Votruba SB, Walter M, Krakoff J, Thearle MS. Increased 24-hour ad libitum food intake is associated with lower plasma irisin concentrations the following morning in adult humans. Appetite. 2015;90:154\u20139.","journal-title":"Appetite."},{"key":"557_CR218","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S0007114518002738","volume":"121","author":"PF Todendi","year":"2019","unstructured":"Todendi PF, Klinger EI, Geraldo A, Brixner L, Reuter CP, Lindenau J, et al. Genetic risk score based on fat mass and obesity-associated, transmembrane protein 18 and fibronectin type III domain containing 5 polymorphisms is associated with anthropometric characteristics in South Brazilian children and adolescents. Br J Nutr. 2019;121:93\u20139.","journal-title":"Br J Nutr"},{"key":"557_CR219","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/0929866525666180508120653","volume":"25","author":"AA Abdu","year":"2018","unstructured":"Abdu AA, Hammoudah SA, Abd EGE, El-Attar LM, Shehab-Eldin WA. Obesity and its association with irisin level among individuals with FNDC5\/Irisin gene variants RS16835198 and RS726344. Protein Pept Lett. 2018;25:560\u20139.","journal-title":"Protein Pept Lett"},{"key":"557_CR220","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1210\/jc.2017-00056","volume":"102","author":"S Petta","year":"2017","unstructured":"Petta S, Valenti L, Svegliati-Baroni G, Ruscica M, Pipitone RM, Dongiovanni P, et al. Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2017;102:2660\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"557_CR221","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2018.10.021","volume":"70","author":"M Metwally","year":"2019","unstructured":"Metwally M, Bayoumi A, Romero-Gomez M, Thabet K, John M, Adams LA, et al. A polymorphism in the irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3\u2019UTR. J Hepatol. 2019;70:494\u2013500.","journal-title":"J Hepatol"},{"key":"557_CR222","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-019-0960-4","volume":"18","author":"H Shirvani","year":"2019","unstructured":"Shirvani H, Rahmati-Ahmadabad S. Irisin interaction with adipose tissue secretions by exercise training and flaxseed oil supplement. Lipids Health Dis. 2019;18:15.","journal-title":"Lipids Health Dis"},{"key":"557_CR223","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/oby.20739","volume":"22","author":"S Bluher","year":"2014","unstructured":"Bluher S, Panagiotou G, Petroff D, Markert J, Wagner A, Klemm T, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity. 2014;22:1701\u20138.","journal-title":"Obesity."},{"key":"557_CR224","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12944-016-0263-y","volume":"15","author":"Y Lu","year":"2016","unstructured":"Lu Y, Li H, Shen SW, Shen ZH, Xu M, Yang CJ, et al. Swimming exercise increases serum irisin level and reduces body fat mass in high-fat-diet fed Wistar rats. Lipids Health Dis. 2016;15:93.","journal-title":"Lipids Health Dis"},{"key":"557_CR225","first-page":"4708287","volume":"2018","author":"KN Tine","year":"2018","unstructured":"Tine KN, Rosalyn SI, Nafi\u2019Ah R. The effects of exercise regimens on irisin levels in obese rats model: comparing high-intensity intermittent with continuous moderate-intensity training. Biomed Res Int. 2018;2018:4708287.","journal-title":"Biomed Res Int"},{"key":"557_CR226","first-page":"596","volume":"18","author":"YS Kang","year":"2019","unstructured":"Kang YS, Kim JC, Kim JS, Kim SH. Effects of swimming exercise on serum irisin and bone FNDC5 in rat models of high-fat diet-induced osteoporosis. J Sports Sci Med. 2019;18:596\u2013603.","journal-title":"J Sports Sci Med"},{"key":"557_CR227","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3390\/nu11102368","volume":"11","author":"I Sajoux","year":"2019","unstructured":"Sajoux I, Lorenzo PM, Gomez-Arbelaez D, Zulet MA, Abete I, Castro AI, et al. Effect of a very-low-calorie ketogenic diet on circulating myokine levels compared with the effect of bariatric surgery or a low-calorie diet in patients with obesity. Nutrients. 2019;11:2368.","journal-title":"Nutrients."},{"key":"557_CR228","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajhb.22493","volume":"26","author":"AB Crujeiras","year":"2014","unstructured":"Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martinez JA, et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014;26:198\u2013207.","journal-title":"Am J Hum Biol"},{"key":"557_CR229","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/cen.12383","volume":"81","author":"R de la Iglesia","year":"2014","unstructured":"de la Iglesia R, Lopez-Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, et al. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol 2014;81:306\u201311.","journal-title":"Clin Endocrinol"},{"key":"557_CR230","doi-asserted-by":"publisher","first-page":"108634","DOI":"10.1016\/j.biopha.2019.108634","volume":"112","author":"J Andrade","year":"2019","unstructured":"Andrade J, Barcala-Jorge AS, Batista-Jorge GC, Paraiso AF, Freitas KM, Lelis DF, et al. Effect of resveratrol on expression of genes involved thermogenesis in mice and humans. Biomed Pharmacother. 2019;112:108634.","journal-title":"Biomed Pharmacother"},{"key":"557_CR231","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamasurg.2019.0424","volume":"154","author":"S Kumar","year":"2019","unstructured":"Kumar S, Hossain J, Inge T, Balagopal PB. Changes in myokines in youths with severe obesity following Roux-en-Y gastric bypass surgery. JAMA Surg. 2019;154:668\u20139.","journal-title":"JAMA Surg"},{"key":"557_CR232","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/ijerph16040660","volume":"16","author":"YJ Lee","year":"2019","unstructured":"Lee YJ, Heo Y, Choi JH, Park S, Kim KK, Shin DW, et al. Association of circulating irisin concentrations with weight loss after Roux-en-Y gastric bypass surgery. Int J Environ Res Public Health. 2019;16:660.","journal-title":"Int J Environ Res Public Health"},{"key":"557_CR233","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.metabol.2012.09.002","volume":"61","author":"JY Huh","year":"2012","unstructured":"Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725\u201338.","journal-title":"Metabolism"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00557-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:27:31Z","timestamp":1723915651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00557-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":233,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00557-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}